What is the Contribution of Maternal Age Compared to Fetal Number When it Comes to Hypertensive Disorders in Pregnancy?
BACKGROUND AND PURPOSE:
Gestational hypertension and preeclampsia rates have increased
Maternal age and multifetal pregnancies have also increased during the same time frame
There is limited data on the effects of maternal age in the context of multifetal gestation
Smith et al. (American Journal of Perinatology 2018) compared the differential contribution and the interaction of fetal number and maternal age to the risk of hypertensive disorders of pregnancy (HDP)
Secondary analyses of the NICHD cesarean registry
Well designed, prospective, multicentered cohort
Participants: Women who had a previous primary cesarean section with singleton, twin, or triplet gestations
Patients were assorted into groups based on
The primary outcome was HDP
HDP: Gestational hypertension, preeclampsia, eclampsia, or HELLP
Incidence of HDP was compared with the reference group and within exposure groups
Logistic regression was used to adjust for confounders
70,417 women were included in the study
HDP occurred in 8,079 (12%) women
The frequency of HDP among the comparison groups ranged from 11 to 38%
When compared with the young maternal age (<35 years) group, the risk of HDP did not increase with maternal age when fetal number was similar until ≥ 40 years
Twin and triplet gestations increased risk for HDP, irrespective of maternal age
Highest risk groups
Advanced maternal age (>35 years) women with twins (OR: 2.0; 95% CI: 1.62–2.57; p < 0.0001)
Advanced maternal age triplets (OR: 2.5; 95% CI: 1.24–5.15; p = 0.012)
Women > 40 years with twins (OR: 3.1; 95% CI: 1.9–4.99; p < 0.0001)
Women > 40 years with triplets (OR: 5.6; 95% CI: 1.32–23.37; p = 0.019)
The authors recognize that they were unable to adjust for nulliparity due to original study design (prior history of cesarean section) which is a significant risk for HDP
The risk of HDP did not significantly increase with maternal age until >40 years of age
Larger number of fetuses per pregnancy increased risk for HDP
This information may be helpful in counseling women
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan